Cd69 expression on regulatory t cells as potential predictor of cardiovascular events risk before immunotherapy
Immunotherapies, specifically immune checkpoint inhibitors (ICIs), have revolutionised cancer treatment by enhancing antitumor immune responses through inhibition of regulatory T cells. However, these treatments can also induce immune-related adverse events (irAEs), including myocarditis, a rare but highly fatal...